RepliCel Life Sciences Inc. RP.V Stock
RepliCel Life Sciences Inc. Price Chart
RepliCel Life Sciences Inc. RP.V Financial and Trading Overview
RepliCel Life Sciences Inc. stock price | 0.06 CAD |
Previous Close | 0.24 CAD |
Open | 0.23 CAD |
Bid | 0.21 CAD x 0 |
Ask | 0.24 CAD x 0 |
Day's Range | 0.23 - 0.24 CAD |
52 Week Range | 0.07 - 0.25 CAD |
Volume | 115K CAD |
Avg. Volume | 7.78K CAD |
Market Cap | 15.6M CAD |
Beta (5Y Monthly) | 1.06514 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.02 CAD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
RP.V Valuation Measures
Enterprise Value | 15.66M CAD |
Trailing P/E | N/A |
Forward P/E | -2 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 44.101894 |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | 44.272 |
Enterprise Value/EBITDA | -10.402 |
Trading Information
RepliCel Life Sciences Inc. Stock Price History
Beta (5Y Monthly) | 1.06514 |
52-Week Change | 100.00% |
S&P500 52-Week Change | 20.43% |
52 Week High | 0.25 CAD |
52 Week Low | 0.07 CAD |
50-Day Moving Average | 0.17 CAD |
200-Day Moving Average | 0.13 CAD |
RP.V Share Statistics
Avg. Volume (3 month) | 7.78K CAD |
Avg. Daily Volume (10-Days) | 18.59K CAD |
Shares Outstanding | 65M |
Float | 23.06M |
Short Ratio | 2.31 |
% Held by Insiders | 55.22% |
% Held by Institutions | 0% |
Shares Short | 16.54K |
Short % of Float | 0.050% |
Short % of Shares Outstanding | 0.029% |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -259.87% |
Operating Margin (ttm) | -425.81% |
Gross Margin | 100.00% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -121.0040% |
Return on Equity (ttm) | N/A |
Income Statement
Revenue (ttm) | 353.74K CAD |
Revenue Per Share (ttm) | 0.008 CAD |
Quarterly Revenue Growth (yoy) | 0% |
Gross Profit (ttm) | N/A |
EBITDA | -1505525 CAD |
Net Income Avi to Common (ttm) | -919267 CAD |
Diluted EPS (ttm) | -0.01 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 697.26K CAD |
Total Cash Per Share (mrq) | 0.01 CAD |
Total Debt (mrq) | 757.38K CAD |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | 0.566 |
Book Value Per Share (mrq) | -0.09 |
Cash Flow Statement
Operating Cash Flow (ttm) | -2194473 CAD |
Levered Free Cash Flow (ttm) | -1213566 CAD |
Profile of RepliCel Life Sciences Inc.
Country | Canada |
State | BC |
City | Vancouver |
Address | 570 Granville Street |
ZIP | V6C 3P1 |
Phone | 604-248-8730 |
Website | https://www.replicel.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | N/A |
RepliCel Life Sciences Inc., a regenerative medicine company, focuses on developing autologous cell therapies that treat functional cellular deficits. Its treatments use autologous cell therapy, which isolates an individual's own cells from harvested tissues and growing more in controlled conditions in a laboratory. The company's product candidates include RCT-01 for the treatment of chronic tendinosis; RCS-01 to treat aging and sun damaged skin; and RCH-01 for the treatment of hair loss. It is also developing RCI-02, a dermal injection device. The company has a collaboration and technology transfer agreement with YOFOTO (China) Health Industry Co. Ltd. for establishing a clinical research program to develop and commercialize RCS-01 and RCT-01; and collaboration and technology transfer agreement with Shiseido Company, Limited for establishing a clinical research program for RCH-01. It also has a collaboration research project agreement with the University of British Columbia to build a hair follicle cell data map. The company is headquartered in Vancouver, Canada.
Q&A For RepliCel Life Sciences Inc. Stock
What is a current RP.V stock price?
RepliCel Life Sciences Inc. RP.V stock price today per share is 0.06 CAD.
How to purchase RepliCel Life Sciences Inc. stock?
You can buy RP.V shares on the TSXV exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for RepliCel Life Sciences Inc.?
The stock symbol or ticker of RepliCel Life Sciences Inc. is RP.V.
Which industry does the RepliCel Life Sciences Inc. company belong to?
The RepliCel Life Sciences Inc. industry is Biotechnology.
How many shares does RepliCel Life Sciences Inc. have in circulation?
The max supply of RepliCel Life Sciences Inc. shares is 65M.
What is RepliCel Life Sciences Inc. Price to Earnings Ratio (PE Ratio)?
RepliCel Life Sciences Inc. PE Ratio is now.
What was RepliCel Life Sciences Inc. earnings per share over the trailing 12 months (TTM)?
RepliCel Life Sciences Inc. EPS is -0.02 CAD over the trailing 12 months.
Which sector does the RepliCel Life Sciences Inc. company belong to?
The RepliCel Life Sciences Inc. sector is Healthcare.